A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma
- PMID: 361132
A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma
Abstract
A preliminary analysis of a controlled trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma has been carried out. The length of follow-up varied from 5 years to 6 months. No obvious benefit from BCG immunotherapy has been found so far. On the other hand the treatment is painful with an appreciable morbidity. Skin tests for delayed hypersensitivity have shown no recognisable differences in patients treated with surgery and those who also had BCG, or in the pattern of responses in those who developed recurrences and those who did not. In view of these early findings trial entry has been closed.
Similar articles
-
Adjuvant immunotherapy with BCG in stage II malignant melanoma.J Surg Oncol. 1983 Jun;23(2):114-6. doi: 10.1002/jso.2930230215. J Surg Oncol. 1983. PMID: 6343725 Clinical Trial.
-
Adjuvant BCG immunotherapy for stage I and II malignant melanoma.Can Med Assoc J. 1983 Jun 1;128(11):1291-5. Can Med Assoc J. 1983. PMID: 6342739 Free PMC article. Clinical Trial.
-
Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.Dev Biol Stand. 1977 Apr 13-15;38:537-40. Dev Biol Stand. 1977. PMID: 344106
-
Adjuvant therapy of cutaneous malignant melanoma: a critical review.Med Pediatr Oncol. 1985;13(5):244-60. doi: 10.1002/mpo.2950130503. Med Pediatr Oncol. 1985. PMID: 3897817 Review.
-
Adjuvant therapy for melanoma.Curr Opin Oncol. 1997 Mar;9(2):189-204. doi: 10.1097/00001622-199703000-00015. Curr Opin Oncol. 1997. PMID: 9161800 Review.
Cited by
-
Adjuvant BCG immunotherapy for malignant melanoma.Can Med Assoc J. 1984 Oct 1;131(7):744-8. Can Med Assoc J. 1984. PMID: 6383591 Free PMC article. Clinical Trial.
-
Neoadjuvant treatment for stage III and IV cutaneous melanoma.Cochrane Database Syst Rev. 2023 Jan 17;1(1):CD012974. doi: 10.1002/14651858.CD012974.pub2. Cochrane Database Syst Rev. 2023. PMID: 36648215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources